NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Ectopic IRF-1 expression promotes tumor cell death



February 3rd, 2005

Ectopic IRF-1 expression promotes apoptosis in breast tumor cells.

"The overexpression of the inhibitor of apoptosis protein, survivin, may provide tumor cells with a distinct survival advantage in situ; hence, therapeutic strategies have been designed to inhibit its expression," oncologists in the United States explained.

In a recent study, E. Pizzoferrato and coauthors at the University of Pittsburgh "ectopically expressed the interferon regulatory factor (IRF)-1 protein in the breast carcinoma cell lines MDA-MB-468 and SK-BR-3 using a recombinant adenovirus (Ad-IRF-1)."

"By screening microarray analysis of cDNA from the human...


Source: Women's Health Weekly (2005-02-03)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login